Analysts Set Bath & Body Works, Inc. (NYSE:BBWI) PT at $42.50

Bath & Body Works, Inc. (NYSE:BBWI) has been assigned an average recommendation of “Moderate Buy” from the sixteen research firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $42.50.

A number of brokerages recently commented on BBWI. Morgan Stanley lowered their price target on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a report on Thursday, November 21st. UBS Group dropped their target price on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a report on Thursday, August 29th. TD Cowen boosted their target price on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Piper Sandler raised their price target on Bath & Body Works from $35.00 to $36.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 26th. Finally, The Goldman Sachs Group cut their price objective on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating on the stock in a research report on Thursday, August 29th.

Bath & Body Works Price Performance

Shares of BBWI opened at $39.27 on Thursday. The stock has a market capitalization of $8.51 billion, a price-to-earnings ratio of 9.58, a price-to-earnings-growth ratio of 1.44 and a beta of 1.83. Bath & Body Works has a 1 year low of $26.20 and a 1 year high of $52.99. The business’s 50 day simple moving average is $33.43 and its 200-day simple moving average is $34.38.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.58 billion. During the same quarter in the previous year, the business posted $0.48 earnings per share. Bath & Body Works’s quarterly revenue was up 3.1% on a year-over-year basis. On average, sell-side analysts expect that Bath & Body Works will post 3.26 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.04%. Bath & Body Works’s dividend payout ratio (DPR) is currently 19.51%.

Insiders Place Their Bets

In other Bath & Body Works news, CEO Gina Boswell purchased 6,000 shares of the stock in a transaction dated Wednesday, October 9th. The stock was purchased at an average price of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now owns 242,987 shares of the company’s stock, valued at approximately $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.27% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Bath & Body Works

A number of large investors have recently bought and sold shares of BBWI. Anomaly Capital Management LP purchased a new stake in shares of Bath & Body Works during the second quarter valued at about $113,995,000. FMR LLC raised its stake in shares of Bath & Body Works by 17,496.5% during the 3rd quarter. FMR LLC now owns 2,516,127 shares of the company’s stock worth $80,315,000 after acquiring an additional 2,501,828 shares in the last quarter. KBC Group NV lifted its position in Bath & Body Works by 9,023.5% during the third quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock valued at $54,322,000 after acquiring an additional 1,683,160 shares during the last quarter. Erste Asset Management GmbH acquired a new stake in Bath & Body Works in the third quarter valued at approximately $50,483,000. Finally, Lone Pine Capital LLC grew its holdings in Bath & Body Works by 15.8% in the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock worth $441,871,000 after purchasing an additional 1,547,399 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.